[1] Lea AP,Goa KL. Calcipotriol. A review of its pharmacological pro perties and therapeutic efficacy in the management of psoriasis. Clin Immunother, 1996, 5:230-248. [2] 涂平,张建中,杨海珍,等.钙泊三醇软膏治疗寻常型银屑病.中华皮肤科杂志,1995,28:346-347. [3] 方栩,刘承煌.钙泊三醇软膏加强治疗银屑病的临床观察.临床皮肤科杂志,1997,26:381-382. [4] Holick MF. 1,25-Dihydroxyvitamin D3 and the skin: a unique application for the treatment of psoriasis. Proc Soc Exp Biol Med, 1989,191:246-257. [5] Kragballe K. Treatment of psoriasis with calcipotriol and other vitamin D analogues. J Am Acad Dermatol, 1992,27:1001-1008. [6] Milde P, Hauser U, Simon T, et al. Expression of 1,25-dihydroxyvitamin D3 receptors in normal and psoriatic skin. J Invest Dermatol,1991,97:230-239. [7] Kragballe K, Iversen L. Calcipotriol. A new topical antipsoriatic drug. Dermatol Clin, 1993,11:137-141. [8] Park BS, Park JS, Lee DY, et al. Vitamin D receptor polymorphism is associated with psoriasis. J Invest Dermatol, 1999,112:113-116. |